Protective association of Klotho rs495392 gene polymorphism against hepatic steatosis in non-alcoholic fatty liver disease patients

• Published in: Clinical and molecular hepatology Vol. 28; no. 2; pp. 183 - 195
• Main Authors: Liu, Wen-Yue, Zhang, Xiaofang, Li, Gang, Tang, Liang-Jie, Zhu, Pei-Wu, Rios, Rafael S, Zheng, Kenneth I, Ma, Hong-Lei, Wang, Xiao-Dong, Pan, Qiuwei, de Knegt, Robert J, Valenti, Luca, Ghanbari, Mohsen, Zheng, Ming-Hua
• Format: Journal Article
• Language: English
• Published: Korea (South) The Korean Association for the Study of the Liver 01.04.2022; Korean Association for the Study of the Liver; 대한간학회
• Subjects: Genetic Predisposition to Disease; Humans; klotho; Klotho Proteins - genetics; Lipase - genetics; Liver - pathology; Membrane Proteins - genetics; non-alcoholic fatty liver disease; Non-alcoholic Fatty Liver Disease - complications; Non-alcoholic Fatty Liver Disease - diagnosis; Non-alcoholic Fatty Liver Disease - genetics; Original; Polymorphism, Single Nucleotide; rs495392; vitamin d; Vitamin D - metabolism; 내과학; Klotho; Non-alcoholic fatty liver disease; vitamin D; rs495392
• ISSN: 2287-2728; 2287-285X
• DOI: 10.3350/cmh.2021.0301

Non-alcoholic fatty liver disease (NAFLD) is closely associated with metabolic dysfunction. Among the multiple factors, genetic variation acts as important modifiers. Klotho, an enzyme encoded by the klotho (KL) gene in human, has been implicated in the pathogenesis of metabolic dysfunctions. However, the impact of variants in KL on NAFLD risk remains poorly understood. The aim of this study was to investigate the impact of KL rs495392 C>A polymorphism on the histological severity of NAFLD. We evaluated the impact of the KL rs495392 polymorphism on liver histology in 531 Chinese with NAFLD and replicated that in the population-based Rotterdam Study cohort. The interactions between the rs495392, vitamin D, and patatin-like phospholipase domain containing 3 (PNPLA3) rs738409 polymorphism were also analyzed. Carriage of the rs495392 A allele had a protective effect on steatosis severity (odds ratio [OR], 0.61; 95% confidence interval [CI], 0.42-0.89; P=0.010) in Chinese patients. After adjustment for potential confounders, the A allele remained significant with a protective effect (OR, 0.66; 95% CI, 0.45-0.98; P=0.040). The effect on hepatic steatosis was confirmed in the Rotterdam Study cohort. Additional analysis showed the association between serum vitamin D levels and NAFLD specifically in rs495392 A allele carriers, but not in non-carriers. Moreover, we found that the rs495392 A allele attenuated the detrimental impact of PNPLA3 rs738409 G allele on the risk of severe hepatic steatosis. The KL rs495392 polymorphism has a protective effect against hepatic steatosis in patients with NAFLD.